Seeing Is Believing
Currently out of the existing stock ratings of Gavin Clark-Gartner, 73 are a BUY (94.81%), 4 are a HOLD (5.19%).
Analyst Gavin Clark-Gartner, currently employed at EVERCORE, carries an average stock price target met ratio of 44.54% that have a potential upside of 48.53% achieved within 94 days.
Gavin Clark-Gartner’s has documented 154 price targets and ratings displayed on 22 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TENX, at 11-Aug-2026.
Analyst best performing recommendations are on LBPH (LONGBOARD PHARMACEUTICALS).
The best stock recommendation documented was for LBPH (LONGBOARD PHARMACEUTICALS) at 12/22/2023. The price target of $25 was fulfilled within 11 days with a profit of $19 (316.67%) receiving and performance score of 287.88.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Sep-2026
$315
$52.18 (19.85%)
$265
25 days ago
(10-Sep-2026)
6/7 (85.71%)
$60 (23.53%)
115
Buy Since 12-Sep-2025
$303
$40.18 (15.29%)
$298
1 months 15 days ago
(20-Aug-2026)
2/11 (18.18%)
$41.17 (15.72%)
35
Buy Since 09-Dec-2021
$300
$37.18 (14.15%)
$295
1 months 18 days ago
(17-Aug-2026)
14/16 (87.5%)
$49.67 (19.84%)
506
Hold Since 13-Aug-2026
$300
$37.18 (14.15%)
1 months 22 days ago
(13-Aug-2026)
1/2 (50%)
$49.18 (19.61%)
115
Buy Since 23-Jan-2023
$260
$-2.82 (-1.07%)
$235
1 months 25 days ago
(10-Aug-2026)
9/9 (100%)
$12.03 (4.85%)
133
Which stock is Gavin Clark-Gartner most bullish on?
Which stock is Gavin Clark-Gartner most reserved on?
What Year was the first public recommendation made by Gavin Clark-Gartner?